-
Alberta enacts a U.S.-style two-tier health care system
By playing to corporate and surgeon greed, Alberta is undermining the entire Canada Health Act and our public system.
-
Arts and Culture: Nova Scotia’s Undervalued Public Good
A flourishing arts sector means a flourishing province. The arts are not a burden; we are part of the solution. Let’s work together on that…
-
Patients or profits first?
Saskatchewan’s Patient First health plan still leaves the door open to for-profit services
-
Budget cuts are about to wreck Canada’s immigration system
Crunching the numbers on the announced cuts at Immigration, Refugees, and Citizenship Canada shows a bloodbath in the making
-
There’s a long way to go to closing the gender pay gap in Canada
On International Women’s Day, a reminder of the work that remains to be done
-
Ontario students need smaller classes, not another EQAO review
Instead of chasing explanations for low test scores the government should reduce and cap class sizes in Ontario
-
Will Canada govern AI for the public good?
Beyond the AI race, Canada must take real steps to create a sovereign and democratic AI—and do so in coordination with other middle powers
-
Unpacking Alberta’s anti-immigrant and anti-constitutional referendums
Alberta is aiming to use anti-migrant xenophobia to promote an agenda of deregulation and privatization
-
Is the U.S. coming for Canada’s dairy supply management?
Trade reforms pushed by U.S. producers and large retailers in the CUSMA review could further compromise domestic industry
-
World Trade Organization strikes down climate industrial strategy again
Long-standing conflict between trade disciplines and economic support measures plague global green new deals
-
Who Really Benefits from Nova Scotia’s Tax Cuts?
We analyzed the main provincial tax measures introduced in budget 2025-26 and in budget 2026-27.
-
The case for a wealth tax is stronger than ever in Canada
An excerpt from “Cancelling Billionaires Before They Cancel Us: The Urgent Case for a Wealth Tax” by Linda McQuaig & Neil Brooks
-
Health Canada’s drug approval process is not actually broken
Looking at actual rates of new drug approvals shows the Canadian regulator does better than critics claim, although there is still room for improvement
